ISSN   0974-3618  (Print)                    www.rjptonline.org

            0974-360X (Online)

 

 

RESEARCH ARTICLE

 

Separating and determining the effective compounds percentage in Ecballium elaterium L. Cucurbitacins Syria

 

Manal Darwish*, Mohamed Isam Hasan Agha2, Soufi Barkil3, Oussama Mansour4

1Department of  Pharmacognosy, Faculty of  Pharmacy, Al-Andalus University  for Medical Science,

Al-Qdmous, Syria.

2Department of  Pharmacognosy, Faculty of  Pharmacy, Damascus University

3Department of  Toxicology and Pharmacology-Faculty of  Pharmacy-Damascus University

4Department  of  Pharmaceutical  Chemistry, Faculty of  Pharmacy, Al-Alndalus University  for Medical Science, Al-Qdmous, Syria.

*Corresponding Author E-mail: mansouroussama@yahoo.fr

 

ABSTRACT:

The Ecballium elaterium L. which grows in the Mediterranean region is considered one of the well known plants in folk medicine in treating liver diseases, especially  jaundice.  Recent studies have indicated  its effectiveness in this area in addition to its valid use in the treatment of Enfluenza, Analgesic and antipyretic and Anti-in flammation. Its fruit is usually used due to the high percentage of the active ingredients and the ease of extraction without ruining or damaging these active ingredients. This extraction contains a set of tri-terpene compounds responsible for the pharmaceutical effectiveness of the plant. These compounds are called Cucurbitacins and they have several types. The study aims at conducting a series of tests and chemical assay in order to determine the juice content of chemical components and calibrate Cucurbitacins existed in the plant using  the available ways (HPLC). The plant fruit was collected from the coastal region and identified by morphological characteristics of sex and gender. Afterwards, it was manually squeezed , purified, and properly tested to detect and calculate the concentrations of Cucurbitacins especially Cuc I and Cuc E. HPLC Examination of the intense methanolic juice, conducted on the waves (230 nm, 254 nm), has confirmed the  presence of Cuc I and Cuc E (concentration of Cuc E was greater than that of Cuc I ).

 

KEY WORDS: Ecballium elaterium L., Cucurbitacin (Cuc), HPLC.

 


INTRODUCTION:

Ecballium elaterium L, which is from the Cucurbitaceae family(1,2,7) widespread in Syria (the coastal and the southern region)(8), with its active components of the Cucurbitacins has been considered extremely affective in curing many diseases(3,4,5). It is widely used in treating liver diseases particularly (Hepatitis(9)). Moreover, it is used in the treatment of rheumatism(6) Viral disease(9)  ,sinusitis (10)  herpes  zoster(11,12).

 

 

 

 

 

 

Received on 29.03.2015          Modified on 08.04.2015

Accepted on 21.04.2015        © RJPT All right reserved

Research J. Pharm. and Tech. 8(7): July, 2015; Page 829-835

DOI: 10.5958/0974-360X.2015.00135.3

 

The plant includes several elements in its liquid juice, and the intense extract of the ripe fruit consist of proteins, which range in molecular weight between 13 → 103 KDa, lipids, sugars, minerals and Cucurbitacins(2) (Figure1) which are classified as a group of active compounds ( triterpens, tetracyclic) that are different from each other where a set of hydroxyl is in positions C2, C3, C19 and C24, the cationic function is in position C3, the double bond is between C1 and C2, and between C23 and C24, acetalation of the hydroxyl set is in position C26. The taste of the juice is also bitter, and it contains cucurbitacins B, D, E, I, R, and L which lots of biological activities are attributed to. Ecballium elaterium L. is a highly toxic plant and not appropriate for internal use; it causes severe irritation to the digestive tract(2) although it is used to treat liver toxicity(13). The plant extract, especially its fruit, is rich in Elatrium which in large doses may cause nausea and vomiting; moreover, and in case of repeated use, it may cause severe inflammation in the stomach and in testiness that leads to death(14). Ocular exposure can cause conjunctivitis and corneal edema erosion. Dermatitis occurs within minutes of exposure due to the irritation of the mucous membrane with varying degrees of severity (intensity). Intranasal administration can lead to irritation of the mucous membranes, and it is manifested in pharyns, dyspnea, drooling, dysphagia, and upper airway obstruction(15,16).

 

Figure 1: The general structure of Cucurbitacins

 

MATERIALS AND METHODS:

Cucurbitacins I, Cucurbitacins E were obtained from Genay France company, Acetonitrile ACN, Methanol MeOH ,Water H2O for  HPLC (Shamlab Company).

 

·        HPLC type JASCO equipped with the followings:

·        (PU-980 Intelligent HP, UV-detector pump 970 Intelligent UV / VIS).

·        ColumnC18 (250 mmx4.6mm), (Kromasil).

·        Ultrasonic Model 310 T (Germany).

·        Filters measure 0.45μM (Whatman).

·        Rotavpor model 111 BUCHI RE Labconco.

·        Centrifuge Heraeuslobofuge 200.

·        Stirrer model Snijders 34532.

 

Preparation of the Juice:

Ripe fruits were collected from costal region and squeezed to get the crude fruit, filtered in order to remove seeds and the remaining tissues, and then they were centrifuged at 5,000 r / min for 40 minutes. Afterwards, they were filtered twice through membrane filters with the dimensions of 0.45 μM. Clear juice (500 ml) as pale watery liquid was obtained, and it was kept in sterile tubes at a temperature (-20C˚)(2)

 

Analysis of Cucurbitacins of the Juice:(2)

The extraction of the active substances from the fruits was carried by adding the clear  juice, obtained from the former stage, to pure methanol, where 100 ml of the juice was mixed with an equal volume of methanol (100 ml) for two hours at room temperature and using a magnetic motor to ensure homogeneous stirring and distribution in methanol in order to extract the active ingredients(2) properly. It was observed separation of some white parts of the juice which were fibers and proteins. The centrifugation of the solution was carried at speed 10,000 r / min for 15 minutes/ ˚4C in special covered tubes. Afterwards, the floating solution was collected, weighed, and placed in a flask of the rotary evaporator. The temperature was set on  ˚40C, and the pressure inside the flask (65 ± 2 bar). This pressure was suitable to vaporize the methanol from the liquid. This lasted for two hours until full vaporization of the liquid. Eventually, the active substances were obtained and preserved in sterile tubes at temperature -20 ˚C. It is worth mentioning that we have kept juice samples from the various stages of the work (pure water juice, methanolic juice before evaporation).

 

Preparation of Standards:

Cuc E: solution was obtained with concentration of 1 mg / ml (equivalent to 1000 μg / ml). Then, a standardized series was conducted, and the first standardized solution Cuc E was obtained with concentration of 0.1 mg / ml equivalent to 100 μg / ml, and the second standardized solution Cuc E with concentration of 0.01 mg/ml equivalent to10μg/ml.

 

Cuc I : was prepared in the same way and the basic solution was obtained with concentration of 1 mg / ml equivalent to 1000 μg / ml. The first standardized solution Cuc I was obtained with concentration of 0.1 mg / ml equivalent to 100 μg / ml and the second Cuc I with concentration of 0.01 mg / ml equivalent to 10mg / ml. Solutions have been prepared and placed in a sealed airtight glass tubes with labels reading each concentration with the standard name, and they were left untouched and preserved at a temperature of -20 Co until use.

 

High Performance Liquid Chromatography (HPLC):

The work has been done on waves length of (230- 254 nm). A comparison between the two waves length was conducted having in mind that the main work was done on 230 nm wave after testing the results. Since Cucurbitacins are polar materials, they carry at least one hydroxyl group, so C18 non-polar  material was chosen separation within a column that has the dimensions (250 × 4.6 mm). The aqueous mobile phase (including water) was selected provided with organic corrigents of methanol and acetonitrile in which the active substances dissolve in at the rate of methanol / acetonitrile / water 30: 30:40. The used standards Cuc E and CucIwere solved well in methanol, acetonitrile and water especially that these solvents constitute the mobile phase. Pumping system is Isocratic chromatography  flow rate was 1 ml / min and the size of the sample injected was 20μl. We mixed the standards with the extract or the experimented material with the same concentration that was injected for each standard alone, and the extract was injected alone in a process called internal standard injection. (0.1ml) of the second standard solution for Cuc I, (0.1 ml) of the first standard solution for Cuc E, and (0.25ml) from the intense methanolic extract of plant were taken, and then the mixture was extended to (1ml) in the mobile phase. After wards, the obtained extract was injected at the wavelength 230 nm (the principal wave length). This was done after injecting the mixture of the tow standards together alone, and the extract alone in same concentration, that was found in, in the internal standard. Then, the peaks correspondences  and their areas were compared to make sure that the expected peak in extract of Cuc E and Cuc I is the same injected and standardized  material.

 

RESULTS AND DISCUSSION:

Appropriacyof the device at the standard Cuc I: The device was appropriate through injecting five consecutive samples from the standard using the wave length 230 nm and a concentration of 10 μg / ml (Figure 2), and the value of the relative standard deviation RSD was less than 2%

 


 

Figure 2: standard chromatography diagram to Cuc I using HPLC

 


Appropriacy of the device at the standard Cuc E: The device was appropriate through injecting five consecutive samples from the standard using the wave length 230 nm and a concentration of 100 μg / ml, (Figure 3), and the value of the relative standard deviation RSD was less than 2%

 

Figure 3: standard chromatography diagram of Cuc E using HPLC

 


Calculating the concentration of the plant intense extract: Comparing the results of the injection of the extended methanolic extract with standars Cuc I and Cuc E , it is possible the concentration of the plant extract as the following:

 

1-Measuring at 230 nm wave length - concentration of Cuc E in the extended extract = (concentration of standard Cuc E × area of standard Cuc E in extract) / (area of standard Cuc E) = (100 × 674741.218) /1047715.061 = 64.4 µg/ml Thus, the concentration of Cuc E in intense methanolic extract of plant is: (Concentration × volume) before extension = (concentration × volume) after extension Concentration = (64.4 × 1) /0.25=257.6 μg / ml = 0.26mg / ml so Concentration in  the crude juice 100 ml: Concentration = (0.26 × 3) /100=0.008 mg / ml - concentration of Cuc I in the extended extract = (concentration of standard Cuc I × area of standard Cuc E in extract) / (area of standard CucI) = (10 × 660177.860) /302250.596 = 21.8 µg/ml

Thus, the concentration of CucI in intense methanolic extract of plant is: Concentration = (21.8 × 1) /0.25=87.2 μg / ml = 0.09 mg / ml so concentration in  the crude juice 100 ml: Concentration = (0.09 × 3) /100=0.003 mg / ml

 

2- Measuring at 254 nm wave length - concentration of Cuc E in the extended extract = (concentration of standard Cuc E × area of standard Cuc E in extract) / (area of standard Cuc E) = 62.14 µg/ml - concentration of Cuc I in the extended extract = (concentration of standard Cuc I × area of standard Cuc E in extract) / (area of standard Cuc I)21.03=  µg/ml All the previous calculations can be summarized in table (1): Table (1): areas and concentrations of mixed standards together and their concentrations in extract  when use  wave lengths  230 nm, 254 nm


 

 

 

 

Peak Area

Concentration µg/ml

Sample

230 nm Wave Length

254 nm Wave Length

230 nm Wave Length

254 nm Wave Length

543201.504

460949.554

10.00

10.00

Cuc I Standard

2510867.410

2345239.584

100.00

100.00

CucE Standard

302250.596

252338.376

10.00

10.00

Cuc I Mixed Standard (CucI+Cuc E)

1047715.061

876887.589

100.00

100.00

CucE Mixed Standard (CucI+Cuc E)

660177.860

530669.373

21.80

21.03

Cuc I Extract

674741.218

544918.975

64.40

62.14

CucE  Extract

 

 

 

Figure 4: chromatography diagram of  standards mixed  on 230 nm wave length

 

Figure 5: chromatography diagram of  extract mixed  on 230 nm wave length

 

Figure 6: chromatography diagram of  standards mixed  on 254 nm wave lenght

 

Figure 7: chromatography diagram of  extract mixed  on 254 nm wave length


Internal standard injection:

After mixing standards Cuc E and Cuc I with the extract ; it was injected.  comparing areas  and the resulting concentrations with their parallels from the extract, the concentrations were calculated as follows: - concentration of Cuc I compound (extract)= (concentration of Cuc I standard × area of Cuc I extract) / (area of Cuc I standard)  = 10 × 703416.108 / 329366.031    = 21.3566 μg / ml - concentration of Cuc I compound (extract+ standard) = (concentration of  Cuc I standard × area of Cuc I (extract+ standard)) / (area of Cuc I standard)   = 10 × 1031843.718 / 329366.031

= 31.3281 μg / ml - concentration of Cuc E compound (extract) = (concentration of Cuc E standard × area of Cuc E extract) / (area of Cuc I standard) = (100 × 577260.7) /1532809.0481                                               = 37.66μg / ml - concentration of CucE compound (extract+ standard) = (concentration of CucE standard × area of CucE (extract+ standard)) / (area of CucE standard)   = (100 × 2084620.305) /1532809.0481   = 137μg / ml

 

Figures (10,8.9) and Table (2) show that the increase in peaks areas and concentrations belonging to the two compounds Cuc I and Cuc E in the mixture (extract + standards) equals peaks areas and concentrations belonging to the standards, which confirms the presence of the two compounds Cuc I and Cuc E in the studied extract. and the area of the peaks and concentrations that was calculated belong to them:

 


 

Table 2 : concentrations and areas of Cuc I, Cuc E in the standards , extract, and the internal standard

Cuc I Standard

Cuc I Extract

Cuc I Extract)+Standard)

Cuc E Standard

Cuc E Extract

Cuc E Extract)+(Standard

Samples

329366.031

703416.108

1031843.718

1532809.048

577260.700

2084620.305

Peak Area

10.0000

21.3566

31.3281

100.0000

37.6600

137.0000

Concentration

µg/ml

 

Figure 8 : chromatography diagram to standards mixture

 

Figure 9: chromatography diagram for extract mixture

 

Figure 10 : chromatography diagram for  internal standard mixture)

 


CONCLUSION:

The extract content of active substances in this study has been determined by conducting a series of particular chemical tests. Cucurbitacins, particularly compounds Cuc I and Cuc E in juice, has been detected, and their concentrations calculated. The fact that Cucurbitacinsis are responsible for the biological activity of the plant, their existence have been confirmed by the high performance liquid chromatography (HPLC) examination, which was conducted on the wave length (230 nm, 254 nm) to the intense methanolic extract. Concentration of Cuc E compound is greater than the concentration of Cuc I compound.  This result matches international studies and research(2). There is no statistical difference in the concentrations values on the two waves lengths; however, the absorption is bigger and better on the wavelength (230 nm).

 

ACKNOWLEDGEMENT:

I would like to thank Mr. Ayham Aljghami,  Instructor at The Higher Institute of Languages-Tishreen University-Syria, for the language assistance provided during the writing process of this article.

 

REFERENCES:

1-       Youssef A, Mansour  O, A Histological – Chemical Comparative Study of Two Species of Inula (I. Viscosa and I. Graveolens) Distributed in The Syrian Coast, Tishreen University Journal for Research and Scientific Studies – Health Sciences Series, 35, 1; 2013:71- 92.

2-       H´el`ene Greige, et al. Cucurbitacins from Ecballium elaterium juice increase the binding of  bilirubin and ibuprofen to albumin in human plasma , the journal of Elsevier, 169;  2007:53-62.

3-       Essam M.A, et al. Evaporate of Ecbalium elaterium fruit extract for treating viral symptoms, the journal of  United States Patent, 20 ; 2007: 13-16.

4-       Khatib S. Y, et al. Effects of crude Ecballium elaterium juice on isolated rabbit heart, International journal of pharmacology, 31; 1993: 259 -260-261.

5-       Fathi T. Halaweish, et al. Method of using cucurbitacins compounds , the journal of United States Patent, March, 1; 2007: 7-12.

6-       AgilAM, et al. Analgesic and Antipyretic Effects of Ecballium elaterium (L.) A. Richard. Extract in Rodents , the journal of  Phytotherapy Research. 9; 1995: 135-139.

7-       George E et al.   Flora of Syria, Plasetine, and Sinai From The Tourus to Ramuhummed and From Mediteranean Sea To The Syrian Desert, The American press Beirut , Syria ,pp. 322-324.

8-       Finley Ellingwood M.D .The American Materia Medica, Therapeutics and     Pharmacognosy, 1919.

9-       Essam MA , et al. Herbal compositions and treatment methods , the journal of United States Patent., vol.22 ; 2004:1-4.

10-    Elias E. Mazokopakis, et al. The Safety and Efficacy of the Fruit Juice of Ecballium   elaterium in the Treatment of Acute Rhinosinusitis,  the journal of Alternative and Complementary. vol. 15; 2009: 1273-1274.

11-    Essam MA, et al. .Evaporate of Ecbalium elaterium fruit extract for treating viral symptoms, the journal of  United States Patent. 20; 2007: 13-16.

12-    Essam MA , et al. Herbal compositions and treatment methods , the journal of United States Patent. 22; 2004: 1- 4.

13-    Agil A, et al . Isolation of an anti-hepatoxic principle from the juice of Ecballium elaterium, the journal of Planta Med.  65; 1999: 673-675 .

14-    Salhab A S., et al .The Acute Toxicity of the Juice of Ecballium Elatrium (L.) A. Rich, the journal of Crude Drug Res.13; 11.1986.

15-    Raikhlin-Eisenkraft B, et al .Ecbalium elaterium (squirting cucumber)-remedy or poison?, the journal of Clinical Toxicology.38; 2000: 305-308.

16-    Eray O, et al. Severe uvular angioedema caused by intranasal administration of Ecbalium elaterium, the journal of  Vet Hum Toxicol.41;1999: 376-377.